Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
International Journal of Clinical Oncology
Published in: International Journal of Clinical Oncology 4/2007

01-08-2007 | ORIGINAL ARTICLE

Pharmacokinetics and pharmacodynamics of paclitaxel with carboplatin or gemcitabine, and effects of CYP3A5 and MDR1 polymorphisms in patients with urogenital cancers

Authors: Mari Jiko, Ikuko Yano, Eriko Sato, Kazushige Takahashi, Hideyuki Motohashi, Satohiro Masuda, Masahiro Okuda, Noriyuki Ito, Eijiro Nakamura, Takehiko Segawa, Toshiyuki Kamoto, Osamu Ogawa, Ken-ichi Inui

Published in: International Journal of Clinical Oncology | Issue 4/2007

Login to get access
Metadata
Title
Pharmacokinetics and pharmacodynamics of paclitaxel with carboplatin or gemcitabine, and effects of CYP3A5 and MDR1 polymorphisms in patients with urogenital cancers
Authors
Mari Jiko
Ikuko Yano
Eriko Sato
Kazushige Takahashi
Hideyuki Motohashi
Satohiro Masuda
Masahiro Okuda
Noriyuki Ito
Eijiro Nakamura
Takehiko Segawa
Toshiyuki Kamoto
Osamu Ogawa
Ken-ichi Inui
Publication date
01-08-2007
Publisher
Springer-Verlag
Published in
International Journal of Clinical Oncology / Issue 4/2007
Print ISSN: 1341-9625
Electronic ISSN: 1437-7772
DOI
https://doi.org/10.1007/s10147-007-0681-y

Other articles of this Issue 4/2007

International Journal of Clinical Oncology 4/2007 Go to the issue

ORIGINAL ARTICLE

Sentinel node biopsy versus elective lymph node dissection in patients with cutaneous melanoma in a Japanese population

ORIGINAL ARTICLE

Treatment with an oral fluoropyrimidine, S-1, plus cisplatin in patients who failed postoperative gemcitabine treatment for pancreatic cancer: a pilot study

ORIGINAL ARTICLE

The impact of real-time tissue elasticity imaging (elastography) on the detection of prostate cancer: clinicopathological analysis

ORIGINAL ARTICLE

Progression-free survival and overall survival of patients with clear cell carcinoma of the ovary treated with paclitaxel-carboplatin or irinotecan-cisplatin: retrospective analysis

CASE REPORT

A patient with gastric cancer and liver metastases successfully treated with combination chemotherapy including S-1

ORIGINAL ARTICLE

Preliminary experience with a modified premedication protocol that included intravenous diphenhydramine and calcium bromide for the prophylaxis of paclitaxel-related hypersensitivity reactions
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits